Literature DB >> 14960299

Emerging neuroskeletal signalling pathways: a review.

Gary J Spencer1, Ian S Hitchcock, Paul G Genever.   

Abstract

Recent work has demonstrated that neurotransmitters, signalling molecules primarily associated with the nervous system, can have profound effects on the skeleton. Bone cells express a broad range of neurotransmitter receptors and transporters, and respond to receptor activation by initiating diverse intracellular signalling pathways, which modulate cellular function. Evidence of neuronal innervation in skeletal tissues, neurotransmitter release directly from bone cells and functional effects of pharmacological manipulation support the existence of a complex and functionally significant neurotransmitter-mediated signalling network in bone. This review aims to concisely summarise our current understanding of how neurotransmitters affect the skeletal system, focusing on their origin, cellular targets and functional effects in bone.

Mesh:

Substances:

Year:  2004        PMID: 14960299     DOI: 10.1016/S0014-5793(04)00053-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Evidence for light wavelength-specific photoelectrophysiological signaling and memory of excess light episodes in Arabidopsis.

Authors:  Magdalena Szechyńska-Hebda; Jerzy Kruk; Magdalena Górecka; Barbara Karpińska; Stanisław Karpiński
Journal:  Plant Cell       Date:  2010-07-16       Impact factor: 11.277

Review 2.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

3.  Absence of mechanical loading in utero influences bone mass and architecture but not innervation in Myod-Myf5-deficient mice.

Authors:  Cédric Gomez; Valentin David; Nicola M Peet; Laurence Vico; Chantal Chenu; Luc Malaval; Timothy M Skerry
Journal:  J Anat       Date:  2007-03       Impact factor: 2.610

4.  Altered bone development in a mouse model of peripheral sensory nerve inactivation.

Authors:  M A Heffner; M J Anderson; G C Yeh; D C Genetos; B A Christiansen
Journal:  J Musculoskelet Neuronal Interact       Date:  2014-03       Impact factor: 2.041

5.  Functional adaptation to loading of a single bone is neuronally regulated and involves multiple bones.

Authors:  Susannah J Sample; Mary Behan; Lesley Smith; William E Oldenhoff; Mark D Markel; Vicki L Kalscheur; Zhengling Hao; Vjekoslav Miletic; Peter Muir
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

6.  Systemic effects of ulna loading in male rats during functional adaptation.

Authors:  Susannah J Sample; Ryan J Collins; Aliya P Wilson; Molly A Racette; Mary Behan; Mark D Markel; Vicki L Kalscheur; Zhengling Hao; Peter Muir
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

7.  Role of calcitonin gene-related peptide in bone repair after cyclic fatigue loading.

Authors:  Susannah J Sample; Zhengling Hao; Aliya P Wilson; Peter Muir
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

8.  Effect of peripheral neuropathy on bone mineral density in adults with diabetes: A systematic review of the literature and meta-analysis.

Authors:  Mahshid Mohseni; Pooya Hosseinzadeh; Roberto Civitelli; Seth Eisen
Journal:  Bone       Date:  2021-03-20       Impact factor: 4.626

9.  Glutamate signaling in healthy and diseased bone.

Authors:  Robert W Cowan; Eric P Seidlitz; Gurmit Singh
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-19       Impact factor: 5.555

10.  Cumulative inactivation of Nell-1 in Wnt1 expressing cell lineages results in craniofacial skeletal hypoplasia and postnatal hydrocephalus.

Authors:  Xiaoyan Chen; Huiming Wang; Mengliu Yu; Kang Ting; Xinli Zhang; Chia Soo; Jong Kil Kim; Huichuan Qi; Pin Ha; Wenlu Jiang; Eric Chen; Xiangyou Luo; Ryan Brent Needle; Lloyd Baik; Cathryn Yang; Jiejun Shi; Jin Hee Kwak
Journal:  Cell Death Differ       Date:  2019-10-03       Impact factor: 12.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.